Evaluation of abdominal symptoms and gastrointestinal mucosal injuries in patients receiving oral anticoagulant dabigatran

Trial Profile

Evaluation of abdominal symptoms and gastrointestinal mucosal injuries in patients receiving oral anticoagulant dabigatran

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2011

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Famotidine; Rabeprazole; Rebamipide
  • Indications Thrombosis
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top